drugset / Trial / NCT02240589

Memantine for Neuroprotection and Cognitive Enhancement Following Traumatic Brain Injury

NCT02240589

Completed 11 enrolled Indiana University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if memantine can improve cognitive and neuropsychiatric outcomes after severe traumatic brain injury.

Timeline

Start
2014-12
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Memantine Unknown 10 mg